Triple-gated motion and blood pool clearance corrections improve reproducibility of coronary 18F-NaF PET

Joshi NV, Vesey AT, Williams MC, Shah ASV, Calvert PA, Craighead FHM, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet. 2014;383:705–13. Available from: https://doi.org/10.1016/S0140-6736(13)61754-7 . Open Access article distributed under the terms of CC BY.

Cocker MS, Spence JD, Hammond R, Wells G, DeKemp RA, Lum C, et al. [18F]-NaF PET/CT identifies active calcification in carotid plaque. JACC Cardiovasc Imaging. 2017;10:486–8.

Rudd JHF, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105:2708–11.

Tarkin JM, Joshi FR, Evans NR, Chowdhury MM, Figg NL, Shah AV, et al. Detection of atherosclerotic inflammation by68Ga-DOTATATE PET compared to [18F]FDG PET imaging. J Am Coll Cardiol. 2017;69:1774–91.

Dawood M, Büther F, Stegger L, Jiang X, Schober O, Schäfers M, et al. Optimal number of respiratory gates in positron emission tomography: a cardiac patient study. Med Phys. 2009;36:1775–84. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19544796 .

Rubeaux M, Joshi NV, Dweck MR, Fletcher A, Motwani M, Thomson LE, et al. Motion correction of 18F-NaF PET for imaging coronary atherosclerotic plaques. J Nucl Med. 2016;57:54–9. Available from: http://jnm.snmjournals.org/cgi/doi/10.2967/jnumed.115.162990 .

Lassen ML, Kwiecinski J, Cadet S, Dey D, Wang C, Dweck MR, et al. Data-driven gross patient motion detection and compensation: implications for coronary 18 F-NaF PET imaging. J Nucl Med. 2019;60(6):830–6. https://doi.org/10.2967/jnumed.118.217877 .

Massera D, Doris MK, Cadet S, Kwiecinski J, Pawade TA, Peeters FECM, et al. Analytical quantification of aortic valve 18F-sodium fluoride PET uptake. J Nucl Cardiol. 2018. Available from: http://link.springer.com/10.1007/s12350-018-01542-6 . Epub ahead of print.

Doris MK, Otaki Y, Krishnan SK, Kwiecinski J, Rubeaux M, Alessio A, et al. Optimization of reconstruction and quantification of motion-corrected coronary PET-CT. J Nucl Cardiol. 2018. Available from. https://doi.org/10.1007/s12350-018-1317-5 . Epub ahead of print.

Kwiecinski J, Berman DS, Lee S-E, Dey D, Cadet S, Lassen ML, et al. Three-hour delayed imaging improves assessment of coronary 18 F-sodium fluoride PET. J Nucl Med. 2019;60(4):530–5. https://doi.org/10.2967/jnumed.118.217885 .

Bucerius J, Mani V, Moncrieff C, Machac J, Fuster V, Farkouh ME, et al. Optimizing18F-FDG PET/CT imaging of vessel wall inflammation: the impact of18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels. Eur J Nucl Med Mol Imaging. 2014;41:369–83.

National Library of Medicine (U.S.). Dual Antiplatelet Therapy to Reduce Myocardial Injury. 2014. Accessed 4th December 2018 [internet]. Available from: https://clinicaltrials.gov/show/NCT02110303 .

Leipsic J, Abbara S, Achenbach S, Cury R, Earls JP, Mancini GBJ, et al. SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J Cardiovasc Comput Tomogr. 2014;8:342–58.

Lassen ML, Kwiecinski J, Slomka PJ. Gating approaches in cardiac PET imaging. PET Clin. 2019;14:271–9.

Daube-Witherspoon ME, Muehllehner G. Treatment of axial data in three-dimensional PET. J Nucl Med.1987;28:1717–24. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3499493 .

Kwiecinski J, Adamson PD, Lassen ML, Doris MK, Moss AJ, Cadet S, et al. Feasibility of coronary 18F-sodium fluoride PET assessment with the utilization of previously acquired CT angiography. Circ Cardiovasc Imaging. 2018;11:e008325..

Pawade TA, Cartlidge TRG, Jenkins WSA, Adamson PD, Robson P, Lucatelli C, et al. Optimization and reproducibility of aortic valve 18F-fluoride positron emission tomography in patients with aortic stenosis. Circ Cardiovasc Imaging. 2016;9:1–11.

Dweck MR, Chow MWL, Joshi NV, Williams MC, Jones C, Fletcher AM, et al. Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol. 2012;59:1539–48

Kitagawa T, Yamamoto H, Nakamoto Y, Sasaki K, Toshimitsu S, Tatsugami F, et al. Predictive value of 18 F-sodium fluoride positron emission tomography in detecting high-risk coronary artery disease in combination with computed tomography. J Am Heart Assoc. 2018;7(20):e010224. Available from: https://www.ahajournals.org/doi/10.1161/JAHA.118.010224 .

Chen W, Dilsizian V. PET assessment of vascular inflammation and atherosclerotic plaques: SUV or TBR? J Nucl Med. 2015;56:503–4.

Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007;48:932–45.

Laffon E, Lamare F, De Clermont H, Burger IA, Marthan R. Variability of average SUV from several hottest voxels is lower than that of SUVmax and SUVpeak. Eur Radiol. 2014;24:1964–70.

National Library of Medicine (U.S.). Study prediction of recurrent events with 18F-Fluoride. https://ClinicalTrials.gov/show/NCT02278211 . Accessed 4 Dec 2018.

Doris MK, Rubeaux M, Pawade T, Otaki Y, Xie Y, Li D, et al. Motion-corrected imaging of the aortic valve with 18 F-NaF PET/CT and PET/MRI: a feasibility study. J Nucl Med. 2017;58:1811–4. Available from: http://jnm.snmjournals.org/lookup/doi/10.2967/jnumed.117.194597 .

Feng T, Wang J, Fung G, Tsui B. Non-rigid dual respiratory and cardiac motion correction methods after , during , and before image reconstruction for 4D cardiac PET. Phys Med Biol. 2015;61:151–68.